The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study
Open accessAbstract
Key Points: Patients with LCH, risk organs, refractory to standard VBL-steroid regimen have a poor survival, ∼30%. In a phase 2 study, with 5 years’ median follow-up, cladribine and Ara-C was shown to improve the survival up to 85% for this group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Optimal two-stage designs for phase II clinical trials.
Simon, R. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90015-9 · Cited by 3,636
Cited by
Allen, C. E., Merad, M., & McClain, K. L. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1607548 · Cited by 570
Héritier, S., Emile, J.-F., Barkaoui, M.-A., Thomas, C., Fraitag, S., Boudjemaa, S., Renaud, F., Moreau, A., Peuchmaur, M., Chassagne-Clément, C., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.9508 · Cited by 342
Self-citation
Metadata
- Authors
- Donadieu, J., Bernard, F., van Noesel, M., Barkaoui, M., Bardet, O., Mura, R., Arico, M., Piguet, C., Gandemer, V., Armari Alla, C., Clausen, N., Jeziorski, E., Lambilliote, A., Weitzman, S., Henter, J. I., Van Den Bos, C., & the Salvage Group of the Histiocyte Society
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2015-09-17
- Volume
- 126
- Issue
- 12
- Pages
- 1415-1423
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W992317070
- Cited by
- 166
- References
- 1
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study. https://app.cochat.ai/papers/10.1182/blood-2015-03-635151
- The paper
- Donadieu, J., Bernard, F., van Noesel, M., Barkaoui, M., Bardet, O., Mura, R., Arico, M., Piguet, C., Gandemer, V., Armari Alla, C., Clausen, N., Jeziorski, E., Lambilliote, A., Weitzman, S., Henter, J. I., Van Den Bos, C., & the Salvage Group of the Histiocyte Society. (2015). Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study. Blood. https://doi.org/10.1182/blood-2015-03-635151
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.